Skip to content
Roboearth – Lifestyle
Author:
iDEL Therapeutics GmbH
iDEL Therapeutics Appoints Claudia Ulbrich as Chair of its Board of Directors
March 24, 2026
iDEL Therapeutics Launches with €9 Million Seed Financing Led by BiomedVC to Advance Oncology Pipeline Based on Direct Cytosolic Transfer Technology
March 17, 2026